These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

682 related articles for article (PubMed ID: 9788419)

  • 1. Second malignancies after treatment for Ewing's sarcoma: a report of the CESS-studies.
    Dunst J; Ahrens S; Paulussen M; Rübe C; Winkelmann W; Zoubek A; Harms D; Jürgens H
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):379-84. PubMed ID: 9788419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation therapy in Ewing's sarcoma: an update of the CESS 86 trial.
    Dunst J; Jürgens H; Sauer R; Pape H; Paulussen M; Winkelmann W; Rübe C
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):919-30. PubMed ID: 7607966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy in Ewing's sarcoma and PNET of the chest wall: results of the trials CESS 81, CESS 86 and EICESS 92.
    Schuck A; Hofmann J; Rübe C; Hillmann A; Ahrens S; Paulussen M; Jürgens H; Dunst J; Willich N
    Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1001-6. PubMed ID: 9869222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation therapy as local treatment in Ewing's sarcoma. Results of the Cooperative Ewing's Sarcoma Studies CESS 81 and CESS 86.
    Dunst J; Sauer R; Burgers JM; Hawliczek R; Kürten R; Winkelmann W; Salzer-Kuntschik M; Müschenich M; Jürgens H
    Cancer; 1991 Jun; 67(11):2818-25. PubMed ID: 2025847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86.
    Paulussen M; Ahrens S; Dunst J; Winkelmann W; Exner GU; Kotz R; Amann G; Dockhorn-Dworniczak B; Harms D; Müller-Weihrich S; Welte K; Kornhuber B; Janka-Schaub G; Göbel U; Treuner J; Voûte PA; Zoubek A; Gadner H; Jürgens H
    J Clin Oncol; 2001 Mar; 19(6):1818-29. PubMed ID: 11251014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in the treatment of Ewing's sarcoma. The Ewing's Sarcoma Study Group of the German Society of Paediatric Oncology CESS 81.
    Sauer R; Jürgens H; Burgers JM; Dunst J; Hawlicek R; Michaelis J
    Radiother Oncol; 1987 Oct; 10(2):101-10. PubMed ID: 3423301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surgery versus radiotherapy in Ewing's sarcoma with good prognosis. Analysis of the CESS-86 data].
    Dunst J; Hoffmann C; Ahrens S; Jürgens H
    Strahlenther Onkol; 1996 May; 172(5):244-8; discussion 249. PubMed ID: 8633255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung irradiation for Ewing's sarcoma with pulmonary metastases at diagnosis: results of the CESS-studies.
    Dunst J; Paulussen M; Jürgens H
    Strahlenther Onkol; 1993 Oct; 169(10):621-3. PubMed ID: 8235988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extraskeletal Ewing's sarcoma family of tumors in adults: prognostic factors and clinical outcome.
    Tural D; Molinas Mandel N; Dervisoglu S; Oner Dincbas F; Koca S; Colpan Oksuz D; Kantarci F; Turna H; Selcukbiricik F; Hiz M
    Jpn J Clin Oncol; 2012 May; 42(5):420-6. PubMed ID: 22416252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas.
    Kuttesch JF; Wexler LH; Marcus RB; Fairclough D; Weaver-McClure L; White M; Mao L; Delaney TF; Pratt CB; Horowitz ME; Kun LE
    J Clin Oncol; 1996 Oct; 14(10):2818-25. PubMed ID: 8874344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose ifosfamide with mesna uroprotection in Ewing's sarcoma.
    Jürgens H; Exner U; Kühl J; Ritter J; Treuner J; Weinel P; Winkler K; Göbel U
    Cancer Chemother Pharmacol; 1989; 24 Suppl 1():S40-4. PubMed ID: 2503258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No advantages in the addition of ifosfamide and VP-16 to the standard four-drug regimen in the maintenance phase of neoadjuvant chemotherapy of Ewing's sarcoma of bone: results of two sequential studies.
    Bacci G; Picci P; Ruggieri P; Ferrari S; Mercuri M; Fabbri N; Rosito P; Barbieri E; Ferraro A; Casadei R
    J Chemother; 1993 Aug; 5(4):247-57. PubMed ID: 8229153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremity.
    Ferrari S; Mercuri M; Rosito P; Mancini A; Barbieri E; Longhi A; Rimondini S; Cesari M; Ruggieri P; Di Liddo M; Bacci G
    J Chemother; 1998 Dec; 10(6):484-91. PubMed ID: 9876058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group.
    Donaldson SS; Torrey M; Link MP; Glicksman A; Gilula L; Laurie F; Manning J; Neff J; Reinus W; Thompson E; Shuster JJ
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):125-35. PubMed ID: 9747829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The German Society of Pediatric Oncology Cooperative Ewing Sarcoma Studies CESS 81/86: report after 6 1/2 years].
    Jürgens H; Bier V; Dunst J; Harms D; Jobke A; Kotz R; Kühl J; Müller-Weihrich S; Ritter J; Salzer-Kuntschik M
    Klin Padiatr; 1988; 200(3):243-52. PubMed ID: 3145357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies.
    Bacci G; Picci P; Ferrari S; Mercuri M; Brach del Prever A; Rosito P; Barbieri E; Tienghi A; Forni C
    Cancer; 1998 Mar; 82(6):1174-83. PubMed ID: 9506366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
    Paulussen M; Craft AW; Lewis I; Hackshaw A; Douglas C; Dunst J; Schuck A; Winkelmann W; Köhler G; Poremba C; Zoubek A; Ladenstein R; van den Berg H; Hunold A; Cassoni A; Spooner D; Grimer R; Whelan J; McTiernan A; Jürgens H;
    J Clin Oncol; 2008 Sep; 26(27):4385-93. PubMed ID: 18802150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The Cooperative Ewing Sarcoma Study CESS 81 of the German Pediatric Oncology Society--analysis after 4 years].
    Jürgens H; Göbel V; Michaelis J; Ramach W; Ritter J; Sauer R; Treuner J; Voûte PA; Winkler K; Göbel U
    Klin Padiatr; 1985; 197(3):225-32. PubMed ID: 3892151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of prognostic factors in a tumor volume-adapted treatment strategy for localized Ewing sarcoma of bone: the CESS 86 experience. Cooperative Ewing Sarcoma Study.
    Ahrens S; Hoffmann C; Jabar S; Braun-Munzinger G; Paulussen M; Dunst J; Rübe C; Winkelmann W; Heinecke A; Göbel U; Winkler K; Harms D; Treuner J; Jürgens H
    Med Pediatr Oncol; 1999 Mar; 32(3):186-95. PubMed ID: 10064186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-metastatic Ewing's sarcoma: results in 98 patients treated with neoadjuvant chemotherapy.
    Bacci G; Ferrari S; Avella M; Barbieri E; Picci P; Casadei R; Rosito P; Neri S; Capanna R; Battistini A
    Ital J Orthop Traumatol; 1991 Dec; 17(4):449-65. PubMed ID: 1816151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.